Lotus Eye Hospital And Institute Ltd Stock Analysis

BSE: 532998 | NSE: LOTUSEYE | Hospital & Healthcare Services | Small Cap

BSE Share Price 06-Feb-2023 18:01
68.80 -1.20 (-1.71%)

DeciZen - Make an Informed Decision on Lotus Eye Hospital

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity

1. Quality

2. Valuation

Overvalued

3. Price Trend

Semi Strong

Lotus Eye Hospital Price Chart

P/E Ratio ( SA) :
34.10
Market Cap :
143.1 Cr.
52-wk low :
42.1
52-wk high :
96.9
Bole Toh?

1. Is Lotus Eye Hospital And Institute Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Lotus Eye Hospital And Institute Ltd is a below average quality company.

2. Is Lotus Eye Hospital And Institute Ltd undervalued or overvalued?

The key valuation ratios of Lotus Eye Hospital And Institute Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Lotus Eye Hospital And Institute Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Lotus Eye Hospital And Institute Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Lotus Eye Hospital:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Lotus Eye Hospital And Institute Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22TTM
ROCE % 0.9%0.1%-3.8%0.4%1.1%3.6%1.7%3.4%3.1%5.8%-
Value Creation Index -0.9-1.0-1.3-1.0-0.9-0.7-0.9-0.8-0.8-0.6-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 29.128.729.931.1343838.440.632.438.946
YoY Gr. Rt. %--1.4%4.2%4.1%9.1%12%1.1%5.5%-20.2%20.2%-
Adj EPS 0.20-10.10.20.80.30.80.71.42
YoY Gr. Rt. %--90%-4900%NA340%277.3%-59%120.6%-2.7%97.3%-
BVPS (₹) 24.724.723.823.824.124.424.124.725.326.326.9
Adj Net Profit 0.40-20.10.51.70.71.61.534
Cash Flow from Ops. 3.74.42.43.435.84.252.74.4-
Debt/CF from Ops. 0.100.40.20.20.10.10.10.10-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 3.3%2.8%0.4%20.2%
Adj EPS 24.5%45.6%61.8%97.3%
BVPS 0.71.82.93.6
Share Price 24.5% 18.1% 38.3% 2.8%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22TTM
Return on Equity % 0.80.1-40.20.93.41.43.12.95.67.6
Op. Profit Mgn % 10.59.54.610.29.811.58.49.811.215.316.7
Net Profit Mgn % 1.40.1-6.70.31.44.51.83.84.77.79.2
Debt to Equity 00000000000
Working Cap Days 10812311598939692728876116
Cash Conv. Cycle -16-34-1-1-9-7-6-9-1066

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 7.60%

Net Profit is growing at healthy rate in last 3 years 61.79%

Sales growth is good in last 4 quarters at 31.96%

Sales growth has been subdued in last 3 years 0.41%

Latest Financials - Lotus Eye Hospital And Institute Ltd.

Standalone Consolidated
TTM EPS (₹) 2 -
TTM Sales (₹ Cr.) 45.9 -
BVPS (₹.) 26.9 -
Reserves (₹ Cr.) 35 -
P/BV 2.56 -
PE 34.10 -
From the Market
52 Week Low / High (₹) 42.05 / 96.90
All Time Low / High (₹) 4.43 / 96.90
Market Cap (₹ Cr.) 143
Equity (₹ Cr.) 20.8
Face Value (₹) 10
Industry PE 60

Management X-Ray of Lotus Eye Hospital :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.004.164.154.14
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Lotus Eye Hospital

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)

News

Lotus Eye Hospital And Institute Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Lotus Eye Hospital on 06-Feb-2023 18:01 is : 68.80.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 06-Feb-2023 18:01 the market cap of Lotus Eye Hospital stood at ₹ 143.1.
The latest PE ratio of Lotus Eye Hospital as of 06-Feb-2023 18:01 is 34.10.
The latest PB ratio of Lotus Eye Hospital as of 06-Feb-2023 18:01 is 2.56
The 52-week high of Lotus Eye Hospital is ₹ 96.90 and the 52-week low is ₹ 42.05.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue / sales of Lotus Eye Hospital is ₹ 45.91 ( Cr.) .

About Lotus Eye Hospital And Institute Ltd

Lotus Eye Care Hospital  was originally incorporated as ‘Kalaivani Health Centre Pvt. Ltd.’on March 14,1997 under the Companies Act, 1956 vide Certificate of Incorporation issued by the Registrar of Companies, Tamil Nadu, Coimbatore. The name of the Company was changed to ‘Lotus Eye Care Hospital Pvt. Ltd. on January 23, 2006 and subsequently to ‘Lotus Eye Care Hospital Limited’ upon conversion into Public Limited Company on October 16, 2007 and a fresh certificate of incorporation has been obtained from Registrar of Companies, Tamil Nadu, Coimbatore.

Lotus Eye Care Hospital is a hi-tech super specialty eye care hospital catering its value added service to the society since inception

Lotus is known for its excellence in Ophthalmic services with personalized care. Lotus is committedly pioneering in the technological revolution in eye care and rendering service to thousands of patients from across the globe to see the world better than ever before.

In the year 1998 Lotus introduced Multi Scan Lasik and in the year 2002 Wave front based Esiris Custom Lasik for the first time in India. Lotus was the first Eye Hospital in South East Asia to have performed Epilasik in July 2004. In the year June 2005 Lotus introduced the most advanced technology of Zyoptix Z100 and combined two superior technologies Epilasik and Zyoptix known as Zyoptix Integrated Epilasik to achieve Supervision.

Lotus has a vision of “empowering eyes to illuminate lives”. Lotus Eye Care group is marching towards its vision of becoming India’s best Corporate Hospital with branches in strategic locations where quality eye care is in need, and render world class eye care service to the society.

Dr.SK.Sundaramoorthy and his team of ophthalmic experts, who have highly qualified with vast experience in each specialty, render comprehensive eye care to hundreds of patients daily at their state of the art eye hospitals in Coimbatore, Tirupur and Salem in South India.

Services offered by the company:

  • Specialty Treatments 
  • Institute of Optometry 
  • Community ophthalmology  
  • Medical Tourism
  • Eye Bank

Milestones:

  • 1989- Opening of hospital at R.S.Puram, Coimbatore. The same was under management of LVRT from 1992 to 2006.
  • 2002- Opening of hospital at Peelamedu, Coimbatore
  • 2004 -Opening of hospital at Salem
  • 2007- Opening of hospital at Tirupur

Achievements/ recognition:

  • Lotus was the first Eye Hospital in South East Asia to have performed Epilasik in July 2004.
  • In the year June 2005 Lotus introduced the most advanced technology of Zyoptix Z100 and combined two superior technologies Epilasik and Zyoptix known as Zyoptix Integrated Epilasik to achieve Supervision.
  • 2012 - Life Time Achievement Award to Dr.K.Sundramoorthy by The TamilnaduDr.M.G.R.Medical University.
  • 2014 - For the sake of Governor Award to Dr.K.Sundramoorthy by Rotary International.
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now